Fundz

Endogenex reported raising $9.21 Million in an initial SEC Form D filing, from an offering of $13 Million

PRIVATEFeb 24, 2023$9.2M of $13M raised

Amount Raised

$9.21 Million

$9.21 Million sold, per SEC Form D (first sale Feb 17, 2023)

Round Type

Venture

PlymouthHealthcare

Quick answer

Endogenex raised $9.21 Million in a funding round, dated February 17, 2023. Endogenex is based in Plymouth, Minnesota, United States.

How much did Endogenex raise?
Endogenex raised $9.21 Million in a funding round on February 17, 2023.
What does Endogenex do?
Endogenex is a privately held, clinical-stage company headquartered in Minneapolis, MN.
Where is Endogenex based and how big is it?
Endogenex is based in Plymouth, Minnesota, United States. Fundz records about 27 employees.
Who are the decision-makers at Endogenex?
Fundz holds 2 contacts at Endogenex, including the Chief Medical Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Endogenex that raised within 45 days of this round, from Fundz verified event records.

  • ZealCare, Inc. raised $125K (Seed) on April 3, 2023.
  • It's Elation raised $100K (Seed) on April 3, 2023.
  • TREEHOUSE HEALTH raised $8M on April 3, 2023.
  • PharmaCann Penn raised $9M on April 3, 2023.
  • GPS Orange raised $1.5M (Seed) on April 1, 2023.
  • GPS Orange raised $596K (Seed) on April 1, 2023.

Who to call at Endogenex, and when

A new round usually means Endogenex is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Endogenex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Endogenex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Endogenex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Endogenex

Location

151 CHESHIRE LANE N, SUITE 400

Plymouth, Minnesota, United States

About

Endogenex is a privately held, clinical-stage company headquartered in Minneapolis, MN. Endogenex was founded in partnership with Mayo Clinic to develop therapies to improve outcomes for people living with type 2 diabetes. Endogenex focuses on the principle that effective treatment for type 2 diabetes can extend beyond pharmaceutical options, correct metabolic function, and help people regain control of their blood glucose levels.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Endogenex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsChristopher S., Chief Medical Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Endogenex's next move

See what Strategic adds

Endogenex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.